Prenatal cigarette smoke exposure and postnatal respiratory responses to hypoxia and hypercapnia

Jonathan D Pendlebury1, Kamran Yusuf, Shehr Bano

  • 1Faculty of Medicine, Department of Pediatrics, Alberta Children's Hospital Research Institute, University of Calgary, Alberta, Canada.

Pediatric Pulmonology
|October 27, 2011
PubMed

Insights

Prenatal cigarette smoke exposure impacts respiratory control in 14-day-old rat pups. These effects persist, showing altered responses to hypoxia and hypercapnia, indicating a lasting interaction with thermoregulation.

Area of Science:

  • Physiology
  • Developmental Biology
  • Toxicology

Background:

  • Prenatal cigarette smoke (CS) exposure can disrupt respiratory control in young mammals.
  • Previous studies showed effects at 7 days old, but persistence beyond this critical period was unknown.

Purpose of the Study:

  • To investigate the lasting effects of prenatal CS exposure on respiratory and thermoregulatory responses in 14-day-old rat pups.
  • To assess responses to hypoxia and hypercapnia under varying ambient temperatures.

Main Methods:

  • Studied 95 unanesthetized, spontaneously breathing 14-day-old rat pups exposed to CS or sham conditions prenatally.
  • Recorded respiratory patterns at low (24-25°C) and high (29-30°C) ambient temperatures.
  • Exposed pups to hypoxic and hypercapnic challenges.

Main Results:

  • No gasping was observed in 14-day-old pups.
  • CS-exposed pups showed increased breathing frequency during hypoxia at both temperatures.
  • Thermoregulatory and respiratory responses to hypercapnia were altered in CS-exposed pups, particularly during recovery.

Conclusions:

  • Prenatal CS exposure significantly affects respiratory and thermoregulatory functions at postnatal day 14.
  • These findings highlight a persistent interaction between CS exposure, respiratory control, and thermoregulation during postnatal development.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...